ResearcherSecond Affiliated Hospital of Kunming Medical CollegeActive in the last 2 years

Qiuhong Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9898-3791; OpenAlex author ID A5100738922. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2025: 1 paper

Papers 1

METTL3 and METTL14 drive pancreatic adenocarcinoma progression via m6A-dependent alternative splicing in PANC-1 cells. Last author DOI 10.1007/s12672-025-03393-3 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Dongyun Cun · 1 shared paper, 2025 · strength 0.26
- Paper METTL3 and METTL14 drive pancreatic adenocarcinoma progression via m6A-dependent alternative splicing in PANC-1 cells. DOI 10.1007/s12672-025-03393-3 ↗
Dong Wei · 1 shared paper, 2025 · strength 0.26
- Paper METTL3 and METTL14 drive pancreatic adenocarcinoma progression via m6A-dependent alternative splicing in PANC-1 cells. DOI 10.1007/s12672-025-03393-3 ↗
Bo Tang · 1 shared paper, 2025 · strength 0.26
- Paper METTL3 and METTL14 drive pancreatic adenocarcinoma progression via m6A-dependent alternative splicing in PANC-1 cells. DOI 10.1007/s12672-025-03393-3 ↗
Renchao Zou · 1 shared paper, 2025 · strength 0.26
- Paper METTL3 and METTL14 drive pancreatic adenocarcinoma progression via m6A-dependent alternative splicing in PANC-1 cells. DOI 10.1007/s12672-025-03393-3 ↗
Tao Wu · 1 shared paper, 2025 · strength 0.26
- Paper METTL3 and METTL14 drive pancreatic adenocarcinoma progression via m6A-dependent alternative splicing in PANC-1 cells. DOI 10.1007/s12672-025-03393-3 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.